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Abstract
Following a request from the European Commission, the Panel on Additives and Products or Substances
used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on L-lysine monohydrochloride
and L-lysine sulfate produced using Corynebacterium glutamicum CCTCC M 2015595 when used as
nutritional additive in feed and water for drinking for all animal species. The active substance is L-lysine
and it is produced in two different forms (monohydrochloride or sulfate). Owing to the uncertainties
regarding the possible genetic modiﬁcation of the strain used to obtain the production strain
C. glutamicum CCTCC M 2015595 and on the possible presence of viable cells and DNA of the production
strain in the ﬁnal product, the FEEDAP Panel cannot conclude on the safety of the additives L-lysine HCl
and L-lysine sulfate produced with C. glutamicum CCTCC M 2015595 for the target species, the
consumers, the users and the environment. For both products, the FEEDAP Panel has concerns regarding
the safety for the target species when the additives are administered via water for drinking. In the
absence of data, the FEEDAP Panel cannot conclude on the safety of the additive for the user. The
products under assessment are considered efﬁcacious sources of the amino acid L-lysine for all animal
species. For these products to be as efﬁcacious in ruminants as in non-ruminant species, they require
protection against degradation in the rumen.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Kempex Holland B.V.2 for authorisation of the
products L-lysine monohydrochloride and L-lysine sulfate, when used as a feed additive for all animal
species (category: nutritional additives; functional group: amino acids, their salts and analogues).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application
to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed
additive or new use of a feed additive). The particulars and documents in support of the application were
considered valid by EFSA as of 30 November 2016.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether the
feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the
safety for the target animals, consumer, user and the environment and on the efﬁcacy of the product
L-lysine monohydrochloride and L-lysine sulfate produced by fermentation with Corynebacterium
glutamicum CCTCC M 2015595, when used under the proposed conditions of use (see Section 3.3).
1.2. Additional information
L-Lysine is currently authorised for its use in all animal species as a nutritional additive.3 No
maximum content in feedingstuffs is established in the European Union (EU).
L-Lysine is authorised for use in food,4 cosmetics5 and as a veterinary medicinal product.6,7
L-Lysine hydrochloride is described in a monograph of the European Pharmacopoeia (PhEur 9th
edition, 2017) monograph 01/2008:0930.
The scientiﬁc Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has
published several opinions on the safety and efﬁcacy of L-lysine and/or its salts produced by C. glutamicum
for all animal species (EFSA, 2007a; EFSA FEEDAP Panel, 2015a, 2016, 2019a,b); and three opinions on
the safety and efﬁcacy of concentrated liquid L-lysine (base), concentrated liquid L-lysine
monohydrochloride and/or L-lysine monohydrochloride produced by Escherichia coli for all animal species
(EFSA FEEDAP Panel, 2013, 2014, 2015a,b).
2. Data and Methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier8 in support of the authorisation request for the use of L-lysine monohydrochloride and L-lysine
sulfate produced by fermentation with C. glutamicum CCTCC M 2015595 as a feed additive.
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Kempex Holland B.V. Zeelandsedijk 15, 5408 SL, Volkel, The Netherlands.
3 Commission Directive 88/485/EEC of 26 July 1988 amending the Annex to Council Directive 82/471/EEC concerning certain
products used in animal nutrition. OJ L 239, 30.8.88, pp. 36–39.
4 Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and
young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive
92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the
European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009, OJ L 181,
29.6.2013, p. 35.
5 Commission Decision of 9 February 2006 amending Decision 96/335/EC establishing an inventory and a common nomenclature
of ingredients employed in cosmetic products. OJ L 97, 5.4.2006, pp. 1–528.
6 Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classiﬁcation
regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1.
7 Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community
procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin,
repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the
Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council. OL L 152, 16.6.2009, p. 11.
8 FEED dossier reference: FAD-2016-0052.
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The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA, peer-reviewed scientiﬁc papers, other scientiﬁc reports and
experts’ knowledge, to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the L-lysine monohydrochloride and L-lysine sulfate produced by
fermentation with C. glutamicum CCTCC M 2015595 in animal feed. The Executive Summary of the
EURL report can be found in Annex A.9
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-lysine
monohydrochloride and L-lysine sulfate produced by fermentation with C. glutamicum CCTCC M 2015595
is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on the identity, characterisation and conditions of use of feed additives (EFSA
FEEDAP Panel, 2017a), Guidance on the characterisation of microorganisms used as feed additives or as
production organisms (EFSA FEEDAP Panel, 2018), Guidance on the assessment of the safety of feed
additives for the target species (EFSA FEEDAP Panel, 2017b), Guidance on the assessment of the safety
of feed additives for the consumer (EFSA FEEDAP Panel, 2017c) and Guidance on studies concerning the
safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012).
3. Assessment
The current application is for the authorisation of L-lysine HCl (minimum 78.8% lysine on dry matter
(DM) basis) and L-lysine sulfate (minimum 55% lysine on DM basis) produced by fermentation by a
strain of C. glutamicum (CCTCC M 2015595). These products are intended to be used as a nutritional
additive (functional group: amino acids, their salts and analogues) in feed and/or in water for drinking
for all animal species. The active substance of both forms of the additive is L-lysine.
3.1. Characterisation of the production organism
The applicant purchased a strain of C. glutamicum (1.0563) from the China Center for Type Culture
collection (CCTCC). No information was provided on the origin and history of modiﬁcations of that strain,
including whether or not it has been genetically modiﬁed.10 That strain was chemically and physically
mutated (3 g/L nitroguanidene during 40 min and ultraviolet radiation for 90 s). The mutants were
screened for high lysine production capacity, the production strain was selected and deposited in the
CCTCC with accession number CCTCC M 2015595.11
As no information has been provided on the original strain, it is not possible to assess whether it
has been genetically modiﬁed and sequences of concern eventually introduced that would remain in
the production strain.
3.2. Manufacturing process
9 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2016-0052_lysine.pdf
10 Technical dossier/Supplementary information November 2018/Answers to Sin and Annexes 1.a and 1.b.
11 Technical dossier/Section II/Annex 2.2.1.2b.
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3.3. Conditions of use
According to the applicant, both forms of the additive can be added directly in compound feed,
through complementary feed or through premixtures and they are aimed for all animal species.15 No
proposed inclusion levels are provided, as the optimal daily allowance in quantitative terms depends on
the species, the physiological state of the animal, the performance level and the environmental
conditions, as well as the amino acid composition of the unsupplemented diet.
The applicant states that the additive (both forms) can be used in water but should not be
simultaneously administered via water for drinking and feed.
3.4. L-Lysine monohydrochloride
3.4.1. Characterisation
3.4.1.1. Characterisation of the active substance/additive
L-Lysine HCl (IUPAC name: (2S)-2,6-diaminohexanoic acid monohydrochloride, synonym L-lysine
hydrochloride, a compound identiﬁed with the CAS No 657-27-2 and the EINECS No 211-519-9), has a
molecular weight of 182.65 g/mol. The theoretical content of lysine in lysine monohydrochloride is 80%.
The molecular formula is NH2–(CH2)4–CH(NH2)–COOH–HCl and the molecular structure is given in
Figure 1.
The product contains by speciﬁcation ≥ 78.8% L-lysine on DM basis; ≤ 1% moisture; ≤ 0.5% other
amino acids; ≤ 0.5% total sugars; ≤ 0.3% ash and ≤ 0.05% ammonium salt.16
The average lysine content analysed in six batches was 77.9% (range 76.9–78.7%) on as is basis.17
The content of chloride was calculated to be 20%. The water content was in the range 0.4–0.6%. On
a DM basis, the average lysine content was 78.3% (range 77.4–79.0%) and ﬁve of the six analysed
batches did not meet the speciﬁcation. The sum of quantiﬁed components was on average 98.3%.18
The speciﬁc optical rotation was measured in three batches ranged from +20.7° to +20.9° and
conﬁrm that the additive is the L-stereoisomer of lysine.19
3.4.1.2. Impurities
Analytical data (three batches) on the content of heavy metals (lead, cadmium and mercury) and
arsenic were below the limit of detection (LOD) except one that showed mercury levels of 0.015 mg/kg.20
Dioxins and the sum of dioxin plus dioxin-like PCBs in three batches of the product were < 0.135 ng
WHO-PCDD/F TEQ/kg and < 0.269 ng WHO-PCDD/F-PCB TEQ/kg.21 The concentrations of these
undesirable substances do not raise safety concerns.
Figure 1: Molecular structure of L-lysine HCl
15 Technical dossier/Section 2.5.1 and supplementary information January 2018/Answers FAD-2016-0052/Q7a-f.
16 Technical dossier/Section II/Table 2.1.3a.
17 Technical dossier/Supplementary information January 2018/Annexes Q7a to f. HPLC method accredited by the Dutch
Accreditation Council (L172).
18 Technical dossier/Section II/2.1.3.c CoA 5 batches Lys HCl.pdf.
19 Technical dossier/Supplementary information January 2018/Annex Q8. National standard of the People’s Republic of China for
feed grade L-lysine HCl. Reference values of the Chinese standard for L-lysine HCl range +18.0 to +21.5.
20 Technical dossier/Annex 2.1.4a and supplementary information January 2018/Q11. LOD (in mg/kg) was 0.01 for mercury and
cadmium, 0.04 for arsenic and 0.05 for lead.
21 Technical dossier/Supplementary information January 2018/Annexes Q21.
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Microbiological contamination (analysed in three batches) showed that Salmonella spp. was absent
in 25 g. E. coli, and coliforms most probable number (MPN) was < 30/g, respectively. Yeasts and
ﬁlamentous fungi were not detected.22 Regarding the mycotoxin content the same batches showed
aﬂatoxins (B1, B2, G1, G2), zearalenone, fumonisins (B1, B2), ochratoxin A and deoxynivalenol (DON)
below the LOD. The amounts of the afore mentioned contaminants do not raise safety concerns.
The applicant provided information to support the absence of viable cells of the production strain in
three batches of L-lysine HCl.23 1-g sample was diluted in 9 mL of distilled water (three replicates per
batch) and after 2 h at 22°C shaking the sample every hour, 1 mL of the suspension was spread on LB
plates (2 9 0.5 mL on two different plates). Plates incubated at 30°C for 2 days and 6 days before
inspection of growth. Identiﬁcation of the strains was performed using matrix-assisted laser desorption/
ionisation time-of-ﬂight mass spectrometer (MALDI-TOF) analyses of clones for each batch and of
colonies from the positive control. Every sample presented colonies after 2 days that morphologically
corresponded to C. glutamicum. On day 6, the number of colonies had increased (calculated to range
between 987 and 1,067 colony forming unit (CFU)/g depending on the batch considered) and had
evolved differently by comparison with day 2. Colonies of control plate were identiﬁed as C. glutamicum
as expected. 1–3 colonies of each phenotype were recovered for each replicate. These colonies were
grouped into seven different morphotypes. MALDI-TOF results classiﬁed correctly the positive control as
C. glutamicum, yielded a fully reliable and reproducible result for morphotypes 1 and 2 (Acinetobacter
radioresistens and Pseudomonas fulva, respectively), a reproducible result (genus level) for morphotypes
3–5 (Lactobacillus, Micrococcus and Rhodococcus fascians), and an unreliable result for morphotype 6
(bacteria from desferrioxamine B (DFB) group). Morphotype 7 and seven additional ungrouped colonies
could not be identiﬁed. Morphotypes 3–7 represented < 40 CFU/g of sample.
Although the available data do not indicate the presence of viable cells of the production strain,
uncertainty remains due to the following weaknesses:
– The limited amount of product tested (0.1 g)
– There were viable cells that could not be identiﬁed. The high bacterial growth hampered the
identiﬁcation of all colonies
Therefore, the presence of viable cells of the production strain in the three batches of L-lysine HCl
tested cannot be excluded.
The applicant did not provide conclusive data on the absence of DNA of the production strain in the
ﬁnal product.24 This would be of relevance in the case the original strain was genetically modiﬁed.
3.4.1.3. Physical properties
L-Lysine HCl is a white or light brown powder, with a bulk density of 550–650 kg/m3 at 25°C,25 pH
5.4–5.6 (10% solution at 25°C)26 and a water solubility of about 600 g/L at 20°C.27
The dusting potential (Stauber–Heubach) was analysed in three batches and was 0.2 g/m3 in all
cases.28
Concerning the particle size, three batches were analysed by laser diffraction. The fractions below
100, 50 and 10 lm diameter (v/v) were 3.6–5.9%, 1.6–2.4% and < 1%, respectively.29
3.4.1.4. Stability and homogeneity
The shelf life of the additive was studied in three batches of the additive kept in closed bags either
at room temperature for 1 year or at 40°C for 8 h. No losses were observed.30
The stability of the additive (three batches) in a vitamin/mineral premixture (containing 16 g/kg
choline chloride) was studied when added at 10% and stored in sealed plastic bags at ambient
temperature for 6 months.31 No losses were observed.
22 Technical dossier/Annex 2.1.4a and supplementary information January 2018/Q9. LOD (in µg/kg) was 2 for aﬂatoxins B1, B2,
G1 and G2; 10 for zearalenone; 50 for fumonisins B1 and B2; 5 for ochratoxin A and 134 for deoxynivalenol.
23 Technical dossier/Supplementary information September 2018/Annex 1; supplementary information November 2018/Annex 5.
24 Technical dossier/Section 2.1.4 and Annexes 2.1.4c to e.
25 Technical dossier/Section 2.1.5.
26 Technical dossier/Section II/Annex 2.1.3c.
27 Technical dossier/Section II/Annex 2.5.2a.
28 Technical dossier/Section II/Annex 2.4.3a.
29 Technical dossier/Section II/Annex 2.1.5 and supplementary information January 2018/Q12.
30 Technical dossier/Section II/Annex 2.4.1a and supplementary information January 2018/Q13.
31 Technical dossier/Section II/Annex 2.4.1c and 2.4.1d; supplementary information January 2018/Q14a.
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The stability of the additive (thee batches) was studied in a piglet compound feed (basal diet consisted
on barley and soybean meal, containing tabulated values/calculated nutrients 7.99 g lysine/kg DM and
187 mg choline/kg DM)32 when supplemented at 0.5%. The stability was studied in meal and pelleted
feed. Pelleting conditions, stability during feed processing and storage conditions (packaging and
temperature) were not reported. No losses were observed.33
The stability of the additive (three batches) was studied at a concentration of 0.5% in water for
drinking (equivalent to a concentration of 4 mg lysine/mL) and stored at room temperature for 24 h.34
No losses were detected
The capacity of one batch of L-lysine HCl (one batch) to distribute homogeneously in the piglet
compound feed described above supplemented with 0.5% free lysine was studied in 10 subsamples.
The coefﬁcient of variation (CV) was 2.2%.35
3.4.1.5. Physico-chemical incompatibilities in feed
No physico-chemical incompatibilities in feed are expected with other additives, medicinal products
or other feed materials.
3.4.2. Safety of L-lysine HCl
L-Lysine requirements of different non-ruminant species and animal categories, absorption and
metabolic fate of L-lysine, tolerance to L-lysine excess and the lysine to arginine antagonism have been
described in detail in previous opinions. No safety concerns for ruminants would arise from ruminal
lysine metabolism (EFSA FEEDAP Panel, 2013, 2014). The use of the amino acid ‘per se’ will not raise
safety concerns for the target animals provided it is supplemented in appropriate amounts to the diets.
However, due to the risk of nutritional imbalances and hygienic reasons, associated to the use of
amino acids via water for drinking (EFSA FEEDAP Panel, 2010), the FEEDAP Panel has concerns on the
safety of the use via water for drinking.
Absorption, distribution, metabolism and excretion of L-lysine were described in a previous scientiﬁc
opinion of the EFSA FEEDAP Panel (2013). The use of the amino acid L-lysine itself in animal nutrition
is considered safe for consumers.
The amino acid L-lysine is a physiological and natural component of animals and plants. It is not
excreted as such (but as urea/uric acid and carbon dioxide). The use of L-lysine in animal nutrition
would not lead to any localised increase in the concentration of L-lysine or its metabolites in the
environment.
Potential concerns would arise from the fermentation process. C. glutamicum is regarded by EFSA
to be suitable for the Qualiﬁed Presumption of Safety (QPS) approach to safety assessment only when
used as production organism (EFSA, 2007b; EFSA BIOHAZ Panel, 2019). The identity of the production
strain has been established as C. glutamicum and the absence of antimicrobial resistance has been
proven. However, uncertainty remains regarding the possible genetic modiﬁcation of the original strain
and the introduction of sequences of concern. In addition, the available data do not allow to conclude
on the presence/absence of viable cells and of DNA of the production strain in the ﬁnal product.
Therefore, the FEEDAP Panel cannot conclude on the safety of the additive L-lysine HCl produced by
C. glutamicum CCTCC M 2015595 for the target species, consumer and the environment.
3.4.2.1. Safety for the user
The fractions below 100, 50 and 10 lm diameter (v/v) were 3.6–5.9%, 1.6-2.4% and < 1%,
respectively. The dusting potential was 0.2 g/m3 in all three batches (see Section 3.4.1.3)
No speciﬁc studies to support the assessment of the safety for the user performed with L-lysine
monohydrochloride were available. In the absence of data, the FEEDAP Panel cannot conclude on the
potential of the L-lysine HCl to be toxic by inhalation, irritant to skin or eyes, or on its potential to be a
dermal sensitiser. Furthermore, owing to the uncertainties regarding the possible genetic modiﬁcation
of the original production strain and the presence of viable cells of the production strain in the ﬁnal
product, the FEEDAP Panel cannot conclude on the safety of the additive L-lysine HCl produced using
C. glutamicum CCTCC M 2015595 for the users.
32 Technical dossier/Section II/Annex 2.4.1f.
33 Technical dossier/Section II/Annex 2.4.1d and 2.4.1f.
34 Technical dossier/Section II/Annex 2.4.1g.
35 Technical dossier/Section II/Annex 2.4.1d and 2.4.1f and supplementary information January 2018/Q16.
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3.5. L-Lysine sulfate
3.5.1. Characterisation
3.5.1.1. Characterisation of the active substance/additive
L-Lysine sulfate (CAS No 60343-69-3) has a molecular weight of 390.38 g/mol. The molecular
formula is [NH2–(CH2)4–CH(NH2)–COOH]2 SO4 and the molecular structure is given in Figure 2. The
theoretical content of lysine in the lysine sulfate is 75%.
L-Lysine sulfate solid contains by speciﬁcation ≥ 73% lysine sulfate (≥ 55% lysine on DM basis),
≤ 5% other amino acids, ≤ 7% total sugars, ≤ 4% loss on drying, ≤ 4% residues on ignition, ≤ 3%
ammonium salt and ≥ 6% protein.36
The compositional data of six batches showed an average total lysine concentration of 53.6% on as
is basis (range 51.9–55.8%),37 corresponding to an average 55.4% lysine on a DM basis. Three out of
the six batches analysed did not meet the speciﬁcation. The average sulfate content (calculated from
analysed sulfur) was 19.8% (range 18–21.3%) as is, corresponding to 20.4% on a DM basis. The
calculated proportion of sulfate not associated with lysine in relation to total lysine was about 8.5%.
Water content was on average 3.2% (range 2.4–3.5%). Crude ash was on average 2.2% (range 1.5–
2.7%). Ammonium (measured in three batches) represented 0.6%. The sum of total other amino acids
was 7.5% on a DM basis, total sugars were 0.3% and protein not related to free amino acids
(measured in three batches) averaged 8%.38
As regards the amount of identiﬁed material, three batches were analysed and about 97% of the
material on a DM basis was identiﬁed.
3.5.1.2. Impurities
The content of heavy metals (lead, cadmium and mercury) and arsenic in the additive (three
batches analysed) showed cadmium and lead values below the limit of detection.39 Arsenic ranged
from < 0.04 to 0.14 mg/kg and mercury from < 0.01 to 0.05 mg/kg. Dioxins and the sum of dioxin
plus dioxin-like PCBs in three batches of the product were < 0.137 to 0.247 ng WHO-PCDD/F TEQ/kg
and < 0.269 to 0.367 ng WHO-PCDD/F-PCB TEQ/kg.
Microbiological contamination (analysed in three batches) showed that Salmonella spp. was absent
in 25 g samples. E. coli, and coliforms MPN was < 30/g, respectively. Yeasts and ﬁlamentous fungi
were not detected.40 Regarding the mycotoxin content, the same batches showed aﬂatoxins (B1, B2,
G1, G2), ochratoxin A below the LOD (except one batch which had a concentration of ochratoxin A of
13.8 lg/kg), DON ranged from 457 to 2,917 lg/kg.41 Zearalenone ranged from 73 to 140 lg/kg and
fumonisins (B1, B2) from 240 to 950 lg/kg.
The amounts of the aforementioned contaminants/impurities do not raise safety concerns.
The applicant provided supplementary information to support the absence of viable cells of the
production strain in three batches of L-lysine sulfate.42 A 1-g sample was diluted in 9 mL of distilled water
(three replicates per batch) and after 2 h at 22°C shaking the sample every hour, 1 mL of the suspension
was spread on LB plates (2 9 0.5 mL on two different plates). Plates incubated at 30°C for 2 days and
Figure 2: Molecular structure of L-lysine sulfate
36 Technical dossier/Section II/Table 2.1.3b.
37 Method HPLC accredited by the Dutch Accreditation Council (L172).
38 Technical dossier/Supplementary information January 2018/Annexes Q18a to l.
39 Technical dossier/Section II/Annex 2.1.4b.
40 Technical dossier/Annex 2.1.4b and supplementary information January 2018/Q9.
41 Technical dossier/Annex 2.1.4b and supplementary information January 2018/Q9. LOD (in µg/kg) was 2 for aﬂatoxins B1, B2,
G1 and G2; 5 for ochratoxin A and 134 for deoxynivalenol.
42 Technical dossier/Supplementary information September 2018/Annex 1 and supplementary information November 2018/Annex 5.
L-Lysine HCl and L-lysine sulfate produced using Corynebacterium glutamicum for all animal species
www.efsa.europa.eu/efsajournal 9 EFSA Journal 2019;17(3):5643
6 days before inspection of growth. Identiﬁcation of the strains was performed using MALDI-TOF analyses
of clones for each batch and of colonies from the positive control. Every sample presented colonies after 2
days that morphologically corresponded to C. glutamicum. On day 6, the number of colonies had
increased (calculated to range between 1,597 and 2,190 CFU/g depending on the batch considered) and
had evolved differently by comparison with day 2. One to three colonies of each morphotype were
recovered for each replicate. These colonies were grouped into six different morphotypes. MALDI-TOF
results identiﬁed correctly the positive control as C. glutamicum, yielded a fully reliable and reproducible
result for morphotypes 1 and 2 (Acinetobacter radioresistens and Pseudomonas fulva, respectively), a
reproducible result (genus level) for morphotypes 3 and 4 (Lactobacillus and Rhodococcus fascians), and
an unreliable result for morphotype 5 (bacteria from DFB group). Morphotype 6 and three additional
ungrouped colonies could not be identiﬁed. Morphotypes 2 to 6 represented < 10 CFU/g of sample.
Although the available data do not indicate the presence of viable cells of the production strain,
uncertainty remains due to the following weaknesses:
– The limited amount of product tested (0.1 g).
– There were viable cells that could not be identiﬁed. The high bacterial growth hampered the
identiﬁcation of all colonies.
Therefore, the presence of viable cells of the production strain in the three batches of L-lysine SO4
tested cannot be excluded.
The applicant did not provide conclusive data on the absence of DNA of the production strain in the
ﬁnal product.24 This would be of relevance in the case the original strain was genetically modiﬁed.
3.5.1.3. Physical properties
The product under assessment is a brown to light brown granulate. It has a bulk density of
600–650 g/cm3.25 Its solubility in water is 200 g/L at 20°C.43
Concerning the particle size, three batches were analysed by laser diffraction. The fractions below
100, 50 and 10 lm diameter (v/v) were 0–6.4%, 0–2.7% and ≤ 0.1%, respectively.29
The dusting potential (three batches, Stauber–Heubach method) ranged from < 0.1 to 1 g/m3.44
3.5.1.4. Stability and homogeneity
The shelf life of the additive was studied in three batches of the additive kept in closed bags either
at room temperature for 1 year or at 40°C for 8 h. No losses were observed.45
The stability of the additive (three batches) in a vitamin/mineral premixture (containing 16 g/kg
choline chloride, and apparently 1.5 g/kg lysine) was studied when added at 10% and stored in sealed
plastic bags at room temperature for 3 months.46 Losses ranged from 2.8% to 3.8%.
The stability of the additive (three batches) was studied in a piglet compound feed (basal diet
consisted on barley and soybean meal, containing 0.8% lysine and 187 mg/kg choline)32 when
supplemented at 0.5%. The stability was studied in meal and pelleted feeds, but the pelleting conditions
were not described. Storage conditions were not reported. No losses were observed in the content of
lysine.47
The stability of L-lysine sulfate (three batches) was studied when solved at a concentration of 0.5%
in water for drinking (equivalent to a concentration of 3.74 mg lysine/mL) and stored at room
temperature for 24 h.48 Losses up to 4% were detected.
The capacity of one batch of L-lysine sulfate to distribute homogeneously in the piglet compound
feed (pelleted) described above supplemented with 0.5% free lysine was studied in 10 subsamples.
The CV was 3.5%.47
3.5.1.5. Physico-chemical incompatibilities in feed
No physico-chemical incompatibilities in feed are expected with other additives, medicinal products
or other feed materials.
43 Technical dossier/Supplementary information January 2018/Answer to Q24.
44 Technical dossier/Section II/Annex 2.4.3b.
45 Technical dossier/Section II/Annex 2.4.1b.
46 Technical dossier/Section II/Annex 2.4.1c and 2.4.1e and supplementary information January 2018/Q26.
47 Technical dossier/Section II/Annex 2.4.1e and 2.4.1f.
48 Technical dossier/Section II/Annex 2.4.1h.
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3.5.2. Safety of L-lysine sulfate
General considerations regarding the safety of L-lysine additives have been discussed in
Section 3.4.2.
There is a high inherent content of sulfate in L-lysine sulfate which could be a safety concern for
the target species, depending on the supplementation level and the tolerance of the target species
(EFSA FEEDAP Panel, 2015b).
With regard to the high content of sulfate in L-lysine sulfate, the EFSA FEEDAP Panel (2019b)
already concluded that the formulation of the complete feed should carefully take into account the
maximum tolerable level of total S, as established by NRC (2005) and set in ruminant diets at 3 g S/kg
DM (diet rich in concentrate) and at 5 g S/kg DM (diet rich in roughage) and in non-ruminant diets at
4 g S/kg DM. Also, the contribution of S/sulfate present in water for drinking to the total S intake
should be considered, especially when the content is high.49
The studies, already published in the scientiﬁc literature and provided also by the applicant
(Drewnoski et al. (2014) in feedlot cattle; Kerr et al. (2014), Bobeck et al. (2013) in growing pigs; Kim
et al. (2014) in growing/ﬁnishing pigs and Spears et al. (2011) in steers), conﬁrm the statement by NRC
(2005), as speciﬁed above. Consequently, no negative effects are to be expected at normal use levels for
the target species provided that the total S intake complies with the recommendations of established
scientiﬁc bodies.
Potential concerns would arise from the fermentation process. C. glutamicum is regarded by EFSA
to be suitable for the Qualiﬁed Presumption of Safety (QPS) approach to safety assessment only when
used as production organism (EFSA, 2007b; EFSA BIOHAZ Panel, 2019). The identity of the production
strain has been established as C. glutamicum and the absence of antimicrobial resistance has been
proven. However, uncertainty remains regarding the possible genetic modiﬁcation of the original strain
and the introduction of sequences of concern. In addition, the available data do not allow to conclude
on the presence/absence of viable cells and of DNA of the production strain in the ﬁnal product.
Therefore, the FEEDAP Panel cannot conclude on the safety of the additive L-lysine SO4 produced by C.
glutamicum CCTCC M 2015595 for the target species, consumer and the environment.
3.5.2.1. Safety for the user
In relation to the particle size distribution, the fractions below 100, 50 and 10 lm diameter (v/v)
were 0–6.4%, 0–2.7% and ≤ 0.1%, respectively. The dusting potential ranged from < 1 to 1 g/m3 (see
Section 3.5.1.3).
No speciﬁc toxicity studies for user safety performed with the L-lysine sulfate under assessment
were available. In the absence of data, the FEEDAP Panel cannot conclude on the potential of this
product to be toxic by inhalation, or irritant to skin or eyes, or on its potential to be a dermal
sensitiser. Furthermore, owing to the uncertainties regarding the possible genetic modiﬁcation of the
original production strain and the presence of viable cells of the production strain in the ﬁnal product,
the FEEDAP Panel cannot conclude on the safety of the additive L-lysine sulfate produced with
C. glutamicum CCTCC M 2015595 for the user.
3.6. Efﬁcacy
Efﬁcacy studies are not required for amino acids naturally occurring in proteins of plants and
animals. The nutritional role of the amino acid L-lysine is well established in the scientiﬁc literature. The
efﬁcacy of L-lysine for both non-ruminant and ruminant species was described in two previous EFSA
opinions (EFSA FEEDAP Panel, 2013, 2014). In general, the products L-lysine HCl and L-lysine sulfate
are considered as efﬁcacious sources of the essential amino acid L-lysine for non-ruminant animal
species. For the supplemental L-lysine to be as efﬁcacious in ruminants as in non-ruminant species,
would require protection against degradation in the rumen.
3.7. Post-marketing monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation50 and Good
Manufacturing Practice.
49 See appendix A of EFSA EFSA FEEDAP Panel et al., 2019a,b,2019c.
50 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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4. Conclusions
Owing to the uncertainties regarding the possible genetic modiﬁcation of the strain used to obtain
the production strain and on the possible presence of viable cells and DNA of the production strain in
the ﬁnal product, the FEEDAP Panel cannot conclude on the safety of the additives L-lysine HCl and
L-lysine sulfate produced with C. glutamicum CCTCC M 2015595 for the target species, the consumers,
the users and the environment.
For both products, the FEEDAP Panel has concerns regarding the safety for the target species when
the additives are administered via water for drinking.
In the absence of data, the FEEDAP Panel cannot conclude on the safety of the additive for the user.
The products under assessment are considered efﬁcacious sources of the amino acid L-lysine for all
animal species. For these products to be as efﬁcacious in ruminants as in non-ruminant species, they
require protection against degradation in the rumen.
Documentation provided to EFSA
1) Dossier L-lysine monohydrochloride and L-lysine sulfate from Corynebacterium glutamicum.
September 2016. Submitted by Kempex Holland B.V.
2) Dossier L-lysine monohydrochloride and L-lysine sulfate from Corynebacterium glutamicum.
Supplementary information. January 2018. Submitted by Kempex Holland B.V.
3) Dossier L-lysine monohydrochloride and L-lysine sulfate produced by fermentation with
Corynebacterium glutamicum. Supplementary information. April 2018. Submitted by Kempex
Holland B.V.
4) Dossier L-lysine monohydrochloride and L-lysine sulfate produced by fermentation with
Corynebacterium glutamicum. Supplementary information. September 2018. Submitted by
Kempex Holland B.V.
5) Dossier L-lysine monohydrochloride and L-lysine sulfate produced by fermentation with
Corynebacterium glutamicum. Supplementary information. November 2018. Submitted by
Kempex Holland B.V.
6) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis of L-lysine monohydrochloride and L-lysine sulfate from
Corynebacterium glutamicum CCTCC M 2015595.
7) Comments from Member States.
Chronology
Date Event
16/08/2016 Dossier received by EFSA
23/09/2016 Reception mandate from the European Commission
30/11/2016 Application validated by EFSA – Start of the scientiﬁc assessment
07/02/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: Manufacturing process, conditions
of use, characterisation of the production strain, characterisation of both forms of the additive,
safety for the target species and safety for the user.
28/02/2017 Reception of the Evaluation report of the European Union Reference Laboratory for Feed Additives
01/03/2017 Comments received from Member States
22/01/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
01/03/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation of the production
strain and characterisation of both forms of the additive.
23/04/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
14/05/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation of both forms of
the additive under assessment.
11/09/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
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Date Event
16/10/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation of the production
strain and characterisation of both forms of the additive under assessment.
12/11/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
26/02/2019 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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Abbreviations
CCTCC China Center for Type Culture collection
CAS Chemical Abstracts Service
CFU colony forming unit
CV coefﬁcient of variation
DFB desferrioxamine B
DM dry matter
DON deoxynivalenol
EINECS European Inventory of Existing Commercial Chemical Substances
EURL European Union Reference Laboratory
FEEDAP EFSA Scientiﬁc Panel on additives and products or substances used in animal feed
IEC-UV/FD Ion Exchange Chromatography coupled with post-column derivatisation and Ultraviolet
or Fluorescence Detection
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IUPAC International Union of Pure and Applied Chemistry
LOD limit of detection
MALDI-TOF matrix-assisted laser desorption/ionisation time-of-ﬂight mass spectrometer
MIC minimum inhibitory concentration
MPN most probable number
PCB polychlorinated biphenyl
PCDD polychlorinated dibenzo(p)dioxins
PCDF polychlorinated dibenzofurans
QPS Qualiﬁed Presumption of Safety (QPS
RSDr Relative standard deviation for repeatability
RSDR Relative standard deviation for reproducibility
TEQ Toxin equivalent
WHO World Health Organization
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Annex A – Evaluation report of the analytical methods submitted in
connection with the application for authorisation of L-lysine
monohydrochloride and L-lysine sulfate from Corynebacterium glutamicum
CCTCC M 2015595
In the current application, authorisation is sought under Article 4(1) for L-lysine monohydrochloride
and L-lysine sulfate from Corynebacterium glutamicum CCTCC M 2015595, under the category/
functional group 3(c) ‘nutritional additives’/’amino acids, their salts and analogues’, according to Annex
I of Regulation (EC) No 1831/2003. Authorisation is sought for all animal species. L-lysine is already
authorised as a feed additive under Commission Directive 88/485/EEC.
For the quantiﬁcation of L-lysine monohydrochloride and L-lysine sulfate in feed additive, the Applicant
submitted the ring-trial validated ISO method EN ISO 17180:2013 based on Ion Exchange Chromato-
graphy coupled with post-column derivatisation and Ultraviolet or Fluorescence Detection (IEC-UV/FD).
The following performance characteristics are reported: a relative standard deviation for repeatability
(RSDr) ranging from 0.7 to 1.7%; a relative standard deviation for reproducibility (RSDR) ranging from
1.5 to 2.5%; and a recovery rate (RRec) ranging from 97.8 to 100%. In addition, the EURL identiﬁed the
“L-lysine monohydrochloride monograph” of the Food Chemical Codex (FCC) for the characterisation of
L-lysine monohydrochloride in the feed additive and the generic European Pharmacopoeia monograph on
sulfates (Ph. Eur. 20301) for the identiﬁcation of sulfates in L-lysine sulfate.
For the quantiﬁcation of L-lysine monohydrochloride and L-lysine sulfate in premixtures, feedingstuffs
and water the Applicant submitted the ring-trial validated Community method (Commission Regulation
(EC) No 152/2009) based on IEC coupled with post-column derivatisation using an amino acid analyser or
high performance liquid chromatography equipped with ion exchange column and photometric detection
(UV). This method, designed only for the analysis of premixtures and feedingstuffs, does not distinguish
between the salts and the amino acid enantiomers. The following performance characteristics were
reported for the quantiﬁcation of total lysine: RSDr ranging from 2.1 to 3.5% and RSDR ranging from 3.0
to 13.1%. Since the Applicant provided no experimental data to determine L-lysine in water, the EURL
cannot evaluate nor recommend a method for the ofﬁcial control to determine L-lysine in water. Based on
the performance characteristics presented, the EURL recommends for ofﬁcial control the four standard
methods mentioned above for the identiﬁcation or quantiﬁcation of lysine in the feed additive, premixture
and/or feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary
L-Lysine HCl and L-lysine sulfate produced using Corynebacterium glutamicum for all animal species
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